Trials / Recruiting
RecruitingNCT04295486
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For Venous Thromboembolism (VTE) Following Total Joint Arthroplasty - A Multi-center Prospective Randomized Control Trial.
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 5,478 (estimated)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This research study is attempting to answer the question of whether 81 mg aspirin once daily is as effective as 81 mg aspirin twice daily in preventing blood clots after total joint replacement surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aspirin | Non-enteric coated 81 mg Aspirin tablet. |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2027-03-01
- Completion
- 2027-03-01
- First posted
- 2020-03-04
- Last updated
- 2026-03-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04295486. Inclusion in this directory is not an endorsement.